107 related articles for article (PubMed ID: 11494044)
21. Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases.
Wang Y; Prives C
Nature; 1995 Jul; 376(6535):88-91. PubMed ID: 7596441
[TBL] [Abstract][Full Text] [Related]
22. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
[TBL] [Abstract][Full Text] [Related]
23. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase.
She QB; Bode AM; Ma WY; Chen NY; Dong Z
Cancer Res; 2001 Feb; 61(4):1604-10. PubMed ID: 11245472
[TBL] [Abstract][Full Text] [Related]
24. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
Park US; Park SK; Lee YI; Park JG; Lee YI
Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
[TBL] [Abstract][Full Text] [Related]
26. Involvement of both extracellular signal-regulated kinase and c-jun N-terminal kinase pathways in the 12-O-tetradecanoylphorbol-13-acetate-induced upregulation of p21(Cip1) in colon cancer cells.
Lin SY; Liang YC; Ho YS; Tsai SH; Pan S; Lee WS
Mol Carcinog; 2002 Sep; 35(1):21-8. PubMed ID: 12203364
[TBL] [Abstract][Full Text] [Related]
27. Different mechanisms for inhibition of cell proliferation via cell cycle proteins in PC12 cells by nerve growth factor and staurosporine.
Gollapudi L; Neet KE
J Neurosci Res; 1997 Aug; 49(4):461-74. PubMed ID: 9285522
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylation of E2F-1 by cyclin A-cdk2.
Kitagawa M; Higashi H; Suzuki-Takahashi I; Segawa K; Hanks SK; Taya Y; Nishimura S; Okuyama A
Oncogene; 1995 Jan; 10(2):229-36. PubMed ID: 7838523
[TBL] [Abstract][Full Text] [Related]
29. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
Rao S; Lowe M; Herliczek TW; Keyomarsi K
Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
[TBL] [Abstract][Full Text] [Related]
30. Increased cdc2 and cdk2 kinase activity by retinoid X receptor gamma-mediated transcriptional down-regulation of the cyclin-dependent kinase inhibitor p21Cip1/WAF1 correlates with terminal differentiation of squamous cell carcinoma lines.
Crowe DL; Shuler CF
Cell Growth Differ; 1998 Aug; 9(8):619-27. PubMed ID: 9716179
[TBL] [Abstract][Full Text] [Related]
31. Alpha-bromoacryloyl derivative of distamycin A (PNU 151807): a new non-covalent minor groove DNA binder with antineoplastic activity.
Marchini S; Cirò M; Gallinari F; Geroni C; Cozzi P; D'Incalci M; Broggini M
Br J Cancer; 1999 Jun; 80(7):991-7. PubMed ID: 10362106
[TBL] [Abstract][Full Text] [Related]
32. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
[TBL] [Abstract][Full Text] [Related]
33. A cyclin-dependent kinase inhibitor (p21(WAF1/CIP1)) affects thymidine incorporation in human liver cancer cells.
Gong Y; Deng S; Zhang M; Wang G; Minuk GY; Burczynski F
Br J Cancer; 2002 Feb; 86(4):625-9. PubMed ID: 11870547
[TBL] [Abstract][Full Text] [Related]
34. JNK1, JNK2 and JNK3 are p53 N-terminal serine 34 kinases.
Hu MC; Qiu WR; Wang YP
Oncogene; 1997 Nov; 15(19):2277-87. PubMed ID: 9393873
[TBL] [Abstract][Full Text] [Related]
35. Regulation of cyclin-dependent kinase (Cdk) 2 Thr-160 phosphorylation and activity by mitogen-activated protein kinase in late G1 phase.
Chiariello M; Gomez E; Gutkind JS
Biochem J; 2000 Aug; 349 Pt 3(Pt 3):869-76. PubMed ID: 10903150
[TBL] [Abstract][Full Text] [Related]
36. Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cells.
David-Pfeuty T
Oncogene; 1999 Dec; 18(52):7409-22. PubMed ID: 10602500
[TBL] [Abstract][Full Text] [Related]
37. Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases.
Xiao D; Singh SV
Cancer Res; 2002 Jul; 62(13):3615-9. PubMed ID: 12097262
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of p53 at serine 15 in A549 pulmonary epithelial cells exposed to vanadate: involvement of ATM pathway.
Suzuki K; Inageda K; Nishitai G; Matsuoka M
Toxicol Appl Pharmacol; 2007 Apr; 220(1):83-91. PubMed ID: 17292432
[TBL] [Abstract][Full Text] [Related]
39. The carcinogen 2-acetylaminofluorene inhibits activation and nuclear accumulation of cyclin-dependent kinase 2 in growth-induced rat liver.
Lindeman B; Skarpen E; Oksvold MP; Huitfeldt HS
Mol Carcinog; 2000 Mar; 27(3):190-9. PubMed ID: 10708481
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-6-resistant melanoma cells exhibit reduced activation of STAT3 and lack of inhibition of cyclin E-associated kinase activity.
Böhm M; Schulte U; Funk JO; Raghunath M; Behrmann I; Kortylewski M; Heinrich PC; Kues T; Luger TA; Schwarz T
J Invest Dermatol; 2001 Jul; 117(1):132-40. PubMed ID: 11442760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
